flag patternflag pattern ..enter after breakout or enter between 1228-1265 level with 1221 as stoploss for a target of 1327 -----1370-------1390-------------1424
58.45INR
5.88 BINR
37.28 BINR
42.54 M
About AJANTA PHARMA
Sector
Headquarters
Mumbai
Employees (FY)
10.27 K
Website
Founded
1973
ISIN
INE031B01049
FIGI
BBG000CQGCV0
Ajanta Pharma Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm offers branded generics and generics that serve a range of therapeutic segments such as antibiotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory, and general health. It operates through the following geographical segments: India, Africa, Asia, and USA. The company was founded by Purushottam Bhagwand Agrawal in 1973 and is headquartered in Mumbai, India.
AJANTPHARMNSE:AJANTPHARM
One Can Enter Now ! Or Wait for Retest of the Trendline (BO) Or wait For better R:R ratio
Note :
1.One Can Go long with a Strict SL below the Trendline or Swing Low of Daily Candle.
2. Close, should be good and Clean.
3. R:R ratio should be 1 :2 minimum
4. Plan as per your RISK
Ajanta Pharma-Nice breakout.Ajanta Pharma-Nice breakout.
Capital to be deployed- 20k
Price -1491/1505
Stoploss-1351
Targets-1791
#ajantapharma #nifty50 #NiftyBank #investment #StockMarket #StocksToBuy
AJANTPHARM - Weekly AnalysisIn the Weekly Chart of AJANTPHARM ,
we can see that, after retest it has given a strong pullback.
possibilities are shown in charts.
AJANTAPHARMA view above 1253AJANTAPHARMA view above 1253
Please follow strict risk reward and stop loss if you follow my levels...
Charts for Educational purposes only
Thanks,
V Trade Point
Ajanta Pharma Strong resistance breakoutNSE:AJANTPHARM
Ajanta pharma has given a strong breakout with increasing volume and in medium term it can give good returns. It has also crossed 200 days MA. Nifty pharma has corrected from 14000 to 12000 (almost 15%) and now recovering from bottom.
CMP - 1333
Target 1 - 1450
target 2 - 1550
SL
Chart of the week! Channel BREAK OUT.BUY at LTP. SL 2170.TARGET 2500.Book 50% Profit AT 2500.EXIT remaining 50% When PRICE closes below 50 EMA.HAPPY TRADING FRIENDS!
Ajanta Pharma : long : target 15%- R/R = 3
- AVWAP resistance at 2214
- RS +ve and trending up.
- Pharma index getting stronger
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AJANTPHARM is 2 104.05 INR — it has decreased by 0.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AJANTA PHARMA stocks are traded under the ticker AJANTPHARM.
AJANTA PHARMA is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for AJANTA PHARMA has a max estimate of 2 561.00 INR and a min estimate of 1 748.00 INR.
AJANTPHARM earnings for the last quarter are 15.50 INR whereas the estimation was 15.90 INR which accounts for −2.52% surprise. Estimated earnings for the next quarter are 15.33 INR. See more details about AJANTA PHARMA earnings.
AJANTA PHARMA revenue for the last quarter amounts to 10.28 B INR despite the estimated figure of 10.49 B INR. In the next quarter revenue is expected to reach 10.53 B INR.
Yes, you can track AJANTA PHARMA financials in yearly and quarterly reports right on TradingView.
Like other stocks, AJANTPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AJANTA PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 10.27 K employees. See our rating of the largest employees — is AJANTA PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AJANTA PHARMA EBITDA is 10.65 B INR, and current EBITDA margin is 22.57%. See more stats in AJANTA PHARMA financial statements.